Owens & Minor (NYSE:OMI) Lowered to Hold at StockNews.com

StockNews.com downgraded shares of Owens & Minor (NYSE:OMIFree Report) from a buy rating to a hold rating in a research report sent to investors on Thursday.

OMI has been the subject of a number of other reports. SVB Leerink initiated coverage on shares of Owens & Minor in a research report on Monday, February 26th. They set a market perform rating and a $24.00 price target for the company. Robert W. Baird reduced their target price on shares of Owens & Minor from $28.00 to $24.00 and set a neutral rating for the company in a report on Monday, May 6th. Barclays upped their price target on shares of Owens & Minor from $21.00 to $23.00 and gave the company an equal weight rating in a report on Wednesday, February 21st. Citigroup lifted their price objective on Owens & Minor from $24.00 to $28.00 and gave the company a neutral rating in a research note on Tuesday, April 30th. Finally, Leerink Partnrs restated a market perform rating on shares of Owens & Minor in a research note on Monday, February 26th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and one has assigned a buy rating to the company. According to MarketBeat, the company has a consensus rating of Hold and a consensus target price of $23.29.

View Our Latest Stock Report on OMI

Owens & Minor Trading Up 1.4 %

NYSE:OMI opened at $17.53 on Thursday. The company has a market capitalization of $1.34 billion, a P/E ratio of -34.37, a PEG ratio of 0.56 and a beta of 0.52. The company has a current ratio of 1.16, a quick ratio of 0.56 and a debt-to-equity ratio of 2.17. Owens & Minor has a 12 month low of $13.64 and a 12 month high of $28.35. The firm has a fifty day simple moving average of $23.43 and a 200-day simple moving average of $21.76.

Owens & Minor (NYSE:OMIGet Free Report) last issued its quarterly earnings results on Friday, May 3rd. The company reported $0.19 EPS for the quarter, topping analysts’ consensus estimates of $0.17 by $0.02. Owens & Minor had a positive return on equity of 12.97% and a negative net margin of 0.37%. The company had revenue of $2.61 billion during the quarter, compared to analysts’ expectations of $2.61 billion. During the same quarter in the previous year, the firm posted $0.05 EPS. The firm’s revenue was up 3.6% compared to the same quarter last year. On average, equities research analysts anticipate that Owens & Minor will post 1.53 earnings per share for the current year.

Insider Activity at Owens & Minor

In other Owens & Minor news, SVP Michael Wayne Lowry sold 10,000 shares of the firm’s stock in a transaction that occurred on Tuesday, February 27th. The stock was sold at an average price of $25.00, for a total value of $250,000.00. Following the sale, the senior vice president now directly owns 71,654 shares of the company’s stock, valued at $1,791,350. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other Owens & Minor news, SVP Michael Wayne Lowry sold 10,000 shares of the company’s stock in a transaction on Tuesday, February 27th. The shares were sold at an average price of $25.00, for a total transaction of $250,000.00. Following the completion of the transaction, the senior vice president now directly owns 71,654 shares in the company, valued at $1,791,350. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Heath H. Galloway sold 2,031 shares of Owens & Minor stock in a transaction dated Thursday, May 16th. The shares were sold at an average price of $20.18, for a total transaction of $40,985.58. Following the completion of the sale, the executive vice president now owns 56,898 shares in the company, valued at approximately $1,148,201.64. The disclosure for this sale can be found here. Insiders sold a total of 17,031 shares of company stock worth $415,186 in the last 90 days. Corporate insiders own 3.59% of the company’s stock.

Hedge Funds Weigh In On Owens & Minor

A number of hedge funds have recently made changes to their positions in the company. FMR LLC boosted its stake in shares of Owens & Minor by 10.6% in the third quarter. FMR LLC now owns 11,479,209 shares of the company’s stock worth $185,504,000 after acquiring an additional 1,103,275 shares during the last quarter. Vanguard Group Inc. raised its holdings in Owens & Minor by 1.9% in the 1st quarter. Vanguard Group Inc. now owns 8,749,866 shares of the company’s stock valued at $242,459,000 after acquiring an additional 162,182 shares during the last quarter. Deerfield Management Company L.P. Series C lifted its stake in Owens & Minor by 35.6% in the 3rd quarter. Deerfield Management Company L.P. Series C now owns 6,435,000 shares of the company’s stock worth $103,990,000 after purchasing an additional 1,690,000 shares in the last quarter. Dimensional Fund Advisors LP boosted its holdings in shares of Owens & Minor by 8.4% during the 4th quarter. Dimensional Fund Advisors LP now owns 4,210,991 shares of the company’s stock worth $81,148,000 after purchasing an additional 327,002 shares during the last quarter. Finally, Invesco Ltd. grew its position in shares of Owens & Minor by 12.0% in the third quarter. Invesco Ltd. now owns 1,081,460 shares of the company’s stock valued at $17,476,000 after purchasing an additional 115,995 shares in the last quarter. Institutional investors and hedge funds own 98.04% of the company’s stock.

About Owens & Minor

(Get Free Report)

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.

See Also

Analyst Recommendations for Owens & Minor (NYSE:OMI)

Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.